BiotechTube

Gadobutrol (Gadavist, BAY86-4875)

Phase 1Completed
0 watching 0 views this week💤 Quiet
30
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Magnetic Resonance Imaging

Conditions

Magnetic Resonance Imaging

Trial Timeline

May 16, 2012 → Nov 28, 2013

NCT ID
NCT01544166

About Gadobutrol (Gadavist, BAY86-4875)

Gadobutrol (Gadavist, BAY86-4875) is a phase 1 stage product being developed by Bayer for Magnetic Resonance Imaging. The current trial status is completed. This product is registered under clinical trial identifier NCT01544166. Target conditions include Magnetic Resonance Imaging.

Hype Score Breakdown

Clinical
10
Activity
5
Company
7
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01544166Phase 1Completed

Competing Products

20 competing products in Magnetic Resonance Imaging

See all competitors
ProductCompanyStageHype Score
HRS-9231 + GadobutrolJiangsu Hengrui MedicinePhase 2
52
D1000078 + D1000082 + D1000083 + D1000085AstraZenecaPhase 1
33
Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerPre-clinical
20
Gadobutrol (Gadovist, BAY86-4875) + Gadopentetate Dimeglumine (Magnevist, BAY86-4882)BayerPhase 3
74
Gadoquatrane (BAY1747846)BayerPhase 3
74
Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A) + Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)BayerPhase 2
49
GBCAsBayerPre-clinical
20
Gadobutrol (Gadovist, BAY86-4875)BayerPhase 3
74
BAY1747846BayerPhase 1
30
Gadoterate (Dotarem/Clariscan) + Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerApproved
82
Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + GadoteridolBayerPhase 3
74
Gadobutrol (Gadovist, BAY86-4875)BayerPre-clinical
20
Gadopentetate dimeglumine (Magnevist, BAY86-6661)BayerPhase 3
74
Gadoquatrane (BAY1747846) + Gadobutrol + Gadoterate meglumine + GadoteridolBayerPhase 3
74
Gadobutrol (Gadavist, Gadovist, BAY86-4875)BayerPhase 1
30
Gadobutrol (Gadovist, BAY86-4875)BayerPre-clinical
20
BAY1747846 + Matching placeboBayerPhase 1
30
Gadoquatrane (BAY1747846) 0.03 mmol Gd/kg + Gadoquatrane (BAY1747846) 0.1 mmol Gd/kg + Matching placeboBayerPhase 1
30
Gadobutrol (Gadavist/Gadovist, BAY86-4875)BayerPre-clinical
20
Gadoxetate disodium (Eovist/Primovist, BAY86-4873)BayerPhase 3
74

Other Products from Bayer

TelmisartanApproved
82
Clotrimazole vaginal tablet + FluconazoleApproved
82
Levitra (Vardenafil, BAY38-9456)Approved
82
Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved
82
Rivaroxaban 20 MG + WarfarinApproved
82